A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allograftsBALFOUR, H. H. JR; CHACE, B. A; STAPLETON, J. T et al.The New England journal of medicine. 1989, Vol 320, Num 21, pp 1381-1387, issn 0028-4793Article

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hostsERICE, A; JORDAN, M. C; CHACE, B. A et al.JAMA, the journal of the American Medical Association. 1987, Vol 257, Num 22, pp 3082-3087, issn 0098-7484Article